-transparent.png){kind=logo}
A partially purified extract from thymus tissue termed thymosin Fraction 5 has been shown to reconstitute immunological deficiencies resulting from the lack of thymic function in several animal models, as well as humans with primary and secondary immunodeficiency diseases. Thymosin Fraction 5 consists of a family of polypeptides with molecular weights ranging from 1,000 to 15,000. Several of these polypeptides contribute individually to the biological activity of the parent compound. Two polypeptide components of thymosin Fraction 5, termed thymosin alpha1 and polypeptide beta1, have been characterized chemically and biologically. Thymosin alpha1 is a highly acidic molecule composed of 28 amino acid residues. This polypeptide has potent biological activity and has been found to be 10 to 1,000 times as active as thymosin Fraction 5 in one in vivo and several in vitro bioassay systems designed to measure differentiation and function of thymus-dependent lymphocytes (T cells). Polypeptide beta1, in contrast, is inactive in our bioassay systems, suggesting that it is not involved in thymic hormone action. Sequence analysis and homology studies have indicated that polypeptide beta1, although present in Fraction 5, does not contribute to the biological activity of thymosin Fraction 5.
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
February 1979,
The Journal of biological chemistry,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
May 1979,
Angewandte Chemie (International ed. in English),
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
February 1969,
Biochimica et biophysica acta,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
December 1978,
Proceedings of the National Academy of Sciences of the United States of America,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
September 1981,
Biokhimiia (Moscow, Russia),
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
August 1973,
Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
May 1975,
Journal of biochemistry,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
July 1979,
The Journal of biological chemistry,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
August 1965,
Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
T L Low, and
G B Thurman, and
M McAdoo, and
J McClure, and
J L Rossio, and
P H Naylor, and
A L Goldstein
January 1982,
Biochemical and biophysical research communications,
